AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
MustGrow Biologics Corp.
Video analysis: MGROF
All videosNo video analysis for this stock yet. Request one from our team.
News: MGROF
MustGrow Announces Officer Appointment and Grant of DSUs
Saskatoon, Saskatchewan--(Newsfile Corp. - September 4, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced the appointment of Tyler Reinheimer, CPA, as Director, Finance of the Company and that the board of directors of the Company has authorized and approved the grant of a total of 1,126,954 deferred share units of the Company ("DSUs") to directors (excluding the Company's Chief Excutive Officer and Chief Operating Officer) and Mr. Reinheimer, effective September 3, 2026.
MustGrow Biologics Corp. (MGRO:CA) Q2 2026 Earnings Call Transcript
MustGrow Biologics Corp. (MGRO:CA) Q2 2026 Earnings Call Transcript
MustGrow Announces Second Quarter 2026 Financial Results
Investor Webcast: Monday, August 31 st at 4:00pm ET / 1:00pm PT Register/View Here: https://us02web.zoom.us/webinar/register/1317861230560/WN_oKTSGbCQR1KjX5MnyGC3kw#/registration Please join/register at least 5 minutes prior to the call. Email questions to info@mustgrow.ca before 2:00pm ET, which will be addressed during the Q&A portion of the webcast.
Market One: MustGrow Biologics Receives First Bayer Milestone Payment
Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors. Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.
MustGrow Receives First Milestone Payment from Bayer AG
Bayer AG has paid MustGrow the first development milestone payment. The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa.
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
Saskatoon, Saskatchewan--(Newsfile Corp. - June 26, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2026 annual meeting of shareholders (the "Meeting") held on June 25, 2026. At the Meeting, all director nominees listed in the Company's management information circular dated May 28, 2026, were elected by shareholders as directors of the Company on a vote held by ballot.
MustGrow Closes $3.7 Million Non-Brokered LIFE Offering
Saskatoon, Saskatchewan--(Newsfile Corp. - June 19, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the closing of its previously announced non-brokered private placement of 7,481,541 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of approximately $3,741,000 (the "LIFE Offering"). Each Unit consists of (i) one common share of the Company (each, a "Common Share") and (ii) one common share purchase warrant (each, a "Warrant").
MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Saskatoon, Saskatchewan--(Newsfile Corp. - June 17, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce that, in connection with its previously announced non-brokered private placement of units (each, a "Unit") at a price of $0.50 per Unit, and as a result of strong investor demand, the Company intends to proceed with closing tomorrow, June 18, 2026, by issuing approximately 7.4 million Units, for aggregate gross proceeds to the Company of approximately $3.7 million (the "LIFE Offering"). Each Unit will consist of: (i) one common share in the capital of the Company (each, a "Common Share"); and (ii) one Common Share purchase warrant (each, a "Warrant").
